Table 1.
Relationship between FAK expression and the clinicopathological characteristics of patients with TNBC (n = 69).
| Parameters | n | FAK, n (%) | p-Value | |
|---|---|---|---|---|
| Low | High | |||
| Total | 69 | 33 (47.83) | 36 (52.17) | |
| Age, n (%) | 0.8769 | |||
| ≤40 years | 8 | 4 (14.29) | 4 (12.90) | |
| >40 years | 51 | 24 (85.71) | 27 (87.10) | |
| Size, n (%) | 0.3458 | |||
| ≤2.0 cm | 23 | 13 (39.39) | 10 (28.57) | |
| >2.0 cm | 45 | 20 (60.61) | 25 (71.43) | |
| Grade, n (%) | 0.8793 | |||
| I/II | 29 | 12 (48.00) | 17 (50.00) | |
| III | 30 | 13 (52.00) | 17 (50.00) | |
| Tumor stage, n (%) | 0.4298 | |||
| T1 | 28 | 15 (45.45) | 13 (36.11) | |
| T2/T3 | 41 | 18 (54.55) | 23 (63.89) | |
| Nodal stage, n (%) | 0.015 * | |||
| N0 | 42 | 25 (75.76) | 17 (47.22) | |
| N1/N2/N3 | 27 | 8 (24.24) | 19 (52.78) | |
| Metastatic stage, n (%) | 0.8817 | |||
| M0 | 59 | 28 (84.85) | 31 (86.11) | |
| M1 | 10 | 5 (15.15) | 5 (13.89) | |
| Tumor recurrent, n (%) | 0.3348 | |||
| Absent | 68 | 33 (100.00) | 35 (97.22) | |
| Present | 1 | 0 (0.00) | 1 (2.78) | |
| Survival status, n (%) | <0.01 * | |||
| Survival | 52 | 31 (93.94) | 21 (58.33) | |
| Death | 17 | 2 (6.06) | 15 (41.67) | |
Statistical analysis was performed using the Chi-squared test. * Statistically significant (p < 0.05).